RSS

Biocartis

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

Innovative molecular diagnostics company, Biocartis Group, and biotechnology company, Amgen, have signed a new companion diagnostic (CDx) development agreement for a novel oncology compound. more

News

Molecular diagnostics company, Biocartis, has signed a companion diagnostic (CDx) development agreement with biotechnology company, Amgen, for the Idylla RAS biomarker tests. more

News

Two CE-marked IVD liquid biopsy tests have been launched by molecular diagnostics company, Biocartis Group. — the Idylla ctKRAS Mutation Test and the Idylla ctNRAS-BRAF Mutation Test. more

Technology

Biocartis Group, a molecular diagnostics company, has announced an extension of its partnership with ETPL with a new five-year strategic partnership, focused on the development of molecular diagnostic assays for Biocartis’ Idylla platform. more

News

Biocartis Group, a molecular diagnostics company, has established a US subsidiary, Biocartis US, and has appointed Vishal Sikri as its US general manager. more

News

Pharma companies have been teaming up in the fight against cancer. EPM lists the top 5 cancer fighting collaborations more

Opinion

Biocartis has signed a collaboration agreement with Merck for the development and commercialisation of a new liquid biopsy RAS biomarker test for patients with metastatic colorectal cancer (mCRC) more

News